This approach demonstrates improved copper extraction and reduced arsenic dissolution, indicating an environmentally sustainable metallurgical route.
This study addresses the dual challenges of low copper recovery and persistent arsenic pollution in the bioleaching of low-grade, high-arsenic copper ores containing enargite (Cu3AsS4). Through integrated electrochemical, chemical, and biological investigations, a selective and environmentally sustainable two-stage hybrid leaching process was developed. Electrochemical analysis identified a critical oxidation threshold of ~750 mV governing enargite dissolution. Chemical leaching and X-ray Photoelectron Spectroscopy (XPS) analysis revealed a temperature-dependent sulfur transformation pathway, enabling a staged thermal strategy: flotation below 40 °C to maximize hydrophobic elemental sulfur (S0) formation, and bioleaching at 40–55 °C to promote complete sulfur oxidation to sulfate. Optimization produced a two-stage process comprising 10-day chemical pre-leaching with FeSO4 (10.0 g/L Fe2+) followed by bioleaching, achieving 78.3% copper extraction while suppressing arsenic dissolution to approximately 10%. The use of FeSO4 instead of Fe2(SO4)3 reduces reagent costs by ~70%, saving an estimated CNY 47,250 daily at 1000 t/d scale. Leaching toxicity tests confirm residue As < 0.10 mg/L, meeting non-hazardous waste standards (GB5085.3-2007). This work provides the first integrated demonstration of electrochemical threshold control combined with temperature-dependent sulfur speciation for selective copper extraction from arsenic-bearing enargite ores, offering a scalable, reagent-economical, and environmentally sustainable metallurgical route.
No takes yet. Share an insight, caveat, or question.
Hu et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: